FRESENIUS KABI CANADA LTD — Enoxaparin Importer Profile
Pharmaceutical Importer · #8 buyer for Enoxaparin · $3.8M import value · 96 shipments · CANADA · DGFT Verified
FRESENIUS KABI CANADA LTD is the #8 importer of Enoxaparin from India with $3.8M in import value and 96 verified shipments. FRESENIUS KABI CANADA LTD holds a 2.1% market share in Enoxaparin imports based in CANADA. The company sources from 2 verified suppliers across 20 formulations shipped to 1 country. Overall, FRESENIUS KABI CANADA LTD imports 2 pharmaceutical products worth $8.3M across 2 therapeutic categories.
FRESENIUS KABI CANADA LTD — Enoxaparin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Enoxaparin to FRESENIUS KABI CANADA LTD?
Verified from 96 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BIOLOGICAL E. LIMITED | $3.5M | 89 | 93.6% |
| BIOLOGICAL E LIMITED | $243.7K | 7 | 6.4% |
FRESENIUS KABI CANADA LTD sources Enoxaparin from 2 verified Indian suppliers based on 96 customs records. The primary supplier is BIOLOGICAL E. LIMITED accounting for 93.6% of imports.
How Does FRESENIUS KABI CANADA LTD Compare to Nearest Enoxaparin Importers?
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $12.8M | 255 | $50.0K |
| 3 | BE PHARMACEUTICALS INC | UNITED STATES | $6.9M | 138 | $50.0K |
| 8 | FRESENIUS KABI CANADA LTD ★ | CANADA | $4.3M | 87 | $50.0K |
| 4 | FRESENIUS KABI USA LLC | UNITED STATES | $3.5M | 70 | $50.0K |
| 5 | EVERSANA | UNITED STATES | $3.5M | 70 | $50.0K |
FRESENIUS KABI CANADA LTD ranks #8 among 505 Enoxaparin importers from India. Average shipment value of $50.0K compared to the market average of $116.5K. The closest competitors by value are BOSTON ONCOLOGY ARABIA and BE PHARMACEUTICALS INC.
Where Does FRESENIUS KABI CANADA LTD Import Enoxaparin To?
Destination countries from 96 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $3.8M | 96 | 100.0% |
FRESENIUS KABI CANADA LTD imports Enoxaparin to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $3.8M.
What Enoxaparin Formulations Does FRESENIUS KABI CANADA LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| 51000441 - ENOXAPARIN SODIUM INJECTION, | $1.1M | 24 |
| 51000440 - ENOXAPARIN SODIUM INJECTION, | $616.1K | 14 |
| 51000444 - ENOXAPARIN SODIUM INJECTION, | $462.3K | 14 |
| 51000446 - ENOXAPARIN SODIUM INJECTION, | $300.0K | 6 |
| 51000447 - ENOXAPARIN SODIUM INJECTION, | $263.1K | 8 |
| 51000445 - ENOXAPARIN SODIUM INJECTION, | $244.6K | 8 |
| 51000446 - ENOXAPARIN SODIUM INJECTION,USP (100MG/1ML) CANADA | $150.0K | 3 |
| 51000445 - ENOXAPARIN SODIUM INJECTION,USP (80MG/0.8ML)CANADA | $144.1K | 3 |
| 51000444 - ENOXAPARIN SODIUM INJECTION,USP(60MG/0.6ML) CANADA | $99.9K | 2 |
| 51000446 - ENOXAPARIN SODIUM INJECTION,USP 100MG/1ML CANADA | $50.0K | 1 |
FRESENIUS KABI CANADA LTD imports 20 distinct Enoxaparin formulations from India. The top formulation is 51000441 - ENOXAPARIN SODIUM INJECTION, with 24 shipments worth $1.1M.
Regulatory Requirements: Importing Enoxaparin into Canada
What FRESENIUS KABI CANADA LTD and other importers must comply with to import Enoxaparin from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Enoxaparin
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Enoxaparin from India and How Much Does FRESENIUS KABI CANADA LTD Import?
India exported $58.9M worth of Enoxaparin through 3,309 shipments from 223 suppliers to 118 countries, serving 505 buyers globally. FRESENIUS KABI CANADA LTD imports $3.8M of this total, accounting for 2.1% of India's Enoxaparin exports with 96 shipments from CANADA. This is verified from 96 customs shipment records covering 20 distinct formulations.
What Is the Average Order Value for FRESENIUS KABI CANADA LTD's Enoxaparin Imports?
FRESENIUS KABI CANADA LTD's average Enoxaparin order value is $39.5K per consignment, based on 96 shipments totaling $3.8M. FRESENIUS KABI CANADA LTD is based in CANADA and ranks #8 among all Enoxaparin importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Enoxaparin to FRESENIUS KABI CANADA LTD?
FRESENIUS KABI CANADA LTD sources Enoxaparin from 2 verified Indian suppliers: BIOLOGICAL E. LIMITED ($3.5M, 93.6%), BIOLOGICAL E LIMITED ($243.7K, 6.4%). This is based on 96 customs records.
How Does FRESENIUS KABI CANADA LTD Compare to Other Enoxaparin Importers?
FRESENIUS KABI CANADA LTD ranks #8 among 505 Enoxaparin importers from India with a 2.1% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($20.6M), BOSTON ONCOLOGY ARABIA ($12.8M), BE PHARMACEUTICALS INC ($6.9M). FRESENIUS KABI CANADA LTD processed 96 shipments from CANADA.
About FRESENIUS KABI CANADA LTD
FRESENIUS KABI CANADA LTD imports 2 products worth $8.3M. Beyond Enoxaparin, top products include Sodium. View the complete FRESENIUS KABI CANADA LTD profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Enoxaparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Enoxaparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: FRESENIUS KABI CANADA LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as FRESENIUS KABI CANADA LTD's capped import value divided by total capped export value for Enoxaparin across all Indian exporters.
- 5.Verified Records: This page is backed by 96 individual customs records matching FRESENIUS KABI CANADA LTD importing Enoxaparin, covering 20 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 118+ countries, 505+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Enoxaparin Import Data for FRESENIUS KABI CANADA LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI CANADA LTD's Enoxaparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI CANADA LTD
Full Company Profile →
2 products · $8.3M total trade · 2 categories
FRESENIUS KABI CANADA LTD × Enoxaparin
Verified from customs records
Company Overview
Top Products by FRESENIUS KABI CANADA LTD
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI CANADA LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Enoxaparin. For current order-level data, contact TransData Nexus.